KEROS THERAPEUTICS IN
59.67
08-October-24 15:59:59
15 minutes delayed
Stocks
-0.45
-0.75%
Today's range
59.56 - 61.00
ISIN
N/A
Source
NASDAQ
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2022 Financial Results
03 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
06 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2022 Financial Results
04 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
18 May 2022 06:00:00 By Nasdaq GlobeNewswire
-
17 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 27th Annual Congress of the European Hematology Association
12 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports First Quarter 2022 Financial Results
05 May 2022 08:00:03 By Nasdaq GlobeNewswire
-
09 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 Feb 2022 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Christopher Rovaldi as Chief Operating Officer
31 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
13 Dec 2021 08:00:01 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
22 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
15 Nov 2021 08:00:01 By Nasdaq GlobeNewswire